Lopinavir/Ritonavir COVID-19 Treatment Linked to Bradycardia

FRIDAY, July 17, 2020 -- Lopinavir/ritonavir (LPV/RTV) treatment of COVID-19 is associated with an increased risk for bradycardia, according to a study published online July 9 in Circulation: Arrhythmia and Electrophysiology.
Christophe Beyls,...

Source: Drugs.com - Pharma News - July 17, 2020 Category: Pharmaceuticals Source Type: news